The United States will begin phasing out its financial support for Namibia’s HIV response programs, marking a shift in aid strategy for the southern African nation. For the 2027 fiscal year, the U.S. plans to allocate $45 million to Namibia’s HIV initiatives, after which it will transition to providing only technical cooperation rather than direct funding, according to a joint statement from both governments.

Namibia has received approximately $45 million annually through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) in recent years. Since 2003, the United States has contributed over $1.1 billion to Namibia’s efforts to combat HIV/AIDS. The decision to reduce funding aligns with a broader U.S. policy aimed at encouraging countries to assume greater responsibility for their health programs and reducing dependency on foreign aid.

This move also follows Namibia’s rejection of proposed provisions that would require sharing health data and biological specimens with the United States. Namibian officials cited concerns over privacy, national sovereignty, and legal implications as reasons for declining the data-sharing terms. In response, Washington and Windhoek are reported to be negotiating a new bilateral health agreement to address these issues.

The scale-back in aid for Namibia is part of a wider pattern under the U.S. government’s effort, initially outlined during the Trump administration’s “America First” foreign policy, to revise relationships with aid recipients. Since late last year, the U.S. has entered into agreements with roughly 30 countries, predominantly in Africa, aimed at fostering domestic financing of health programs, minimizing donor dependency, and protecting American strategic interests.

However, not all countries have accepted the proposed terms. Ghana rejected a similar agreement due to concerns over access to sensitive health information. Zimbabwe withdrew from a $367 million program over comparable issues, and a legal challenge has paused Kenya’s $2.5 billion health aid agreement. Zambia has also expressed opposition to data-sharing requirements implicated in these deals.

The U.S. and Namibia’s ongoing discussions highlight the complexities involved in balancing donor requirements with recipient countries’ sovereignty and privacy concerns as the U.S. recalibrates its global health funding priorities.